病毒肝炎干细胞治疗: 全面的概述
病毒肝炎, 全球健康问题, 全世界影响数百万. Traditional therapies have limitations, necessitating the exploration of novel approaches. 干细胞疗法 has emerged as a promising treatment modality, offering potential for disease modification and regeneration.
Current Therapeutic Approaches and Challenges
Current treatments for viral hepatitis include antiviral medications, interferon therapy, 和肝移植. While these approaches can suppress viral replication and improve liver function, they often have limited efficacy, high cost, and potential side effects. 肝移植, the most invasive option, is only applicable to a small number of patients due to organ shortage and high post-operative risks.
The Role of Stem Cells in Hepatitis Management
干细胞, 他们有能力自我更新和分化为各种细胞类型, hold immense therapeutic potential for viral hepatitis. Preclinical studies have demonstrated that stem cells can differentiate into hepatocytes and cholangiocytes, 肝脏的功能细胞. By replacing damaged liver cells, stem cells may restore liver function and reduce inflammation. 此外, stem cells secrete growth factors and cytokines that promote liver regeneration and immune modulation.
